DRESS syndrome: a detailed insight

References

• Sasidharanpillai S, Riyaz N, Khader A, et al. Severe cutaneous adverse drug reactions: a clinicoepidemiological study. Indian J Dermatol. 2015;60:102.
   PubMed Web of Science ®Google Scholar
• Walsh SA, Creamer D. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clin Exp Dermatol. 2011;36:6–11.
   PubMed Web of Science ®Google Scholar
• Begon E, Roujeau J-C. Drug hypersensitivity syndrome: DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). Ann Dermatol Venereol. 2004;131:293–297.
   PubMed Web of Science ®Google Scholar
• Kano Y, Shiohara T. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin North Am. 2009;29:481–501.
   PubMed Web of Science ®Google Scholar
• Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatol Basel Switz. 2003;206:353–356.
   PubMed Web of Science ®Google Scholar
• Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology. 1997;49:542–546.
   PubMed Web of Science ®Google Scholar
• Choudhary S, McLeod M, Torchia D, et al. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. J Clin Aesthetic Dermatol. 2013;6:31–37.
   PubMedGoogle Scholar
• Cho Y-T, Yang C-W, Chu C-Y. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): an interplay among drugs, viruses, and immune system. Int J Mol Sci. 2017;18.
   Web of Science ®Google Scholar
• Lonjou C, Thomas L, Borot N, et al. A marker for Stevens-Johnson syndrome: ethnicity matters. Pharmacogenomics J. 2006;6:265–268.
   PubMed Web of Science ®Google Scholar
• Hung S-I, Chung W-H, Jee S-H, et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics. 2006;16:297–306.
   PubMed Web of Science ®Google Scholar
• Chung W-H, Hung S-I, Hong H-S, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature. 2004;428:486.
   PubMed Web of Science ®Google Scholar
• Mallal S, Phillips E, Carosi G, et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008;358:568–579.
   PubMed Web of Science ®Google Scholar
• Criado PR, Avancini J, Santi CG, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses and the immune system. Isr Med Assoc J IMAJ. 2012;14:577–582.
   PubMed Web of Science ®Google Scholar
• Rieder MJ, Shear NH, Kanee A, et al. Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharmacol Ther. 1991;49:13–17.
   PubMed Web of Science ®Google Scholar
• Tassaneeyakul W, Prabmeechai N, Sukasem C, et al. Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population. Pharmacogenet Genomics. 2016;26:225–234.
   PubMed Web of Science ®Google Scholar
• Suvichapanich S, Jittikoon J, Wichukchinda N, et al. Association analysis of CYP2C9*3 and phenytoin-induced severe cutaneous adverse reactions (SCARs) in Thai epilepsy children. J Hum Genet. 2015;60:413–417.
   PubMed Web of Science ®Google Scholar
• Criado PR, Criado RFJ, Avancini J de M, et al. Drug reaction with Eosinophilia and Systemic Symptoms (DRESS)/Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts. An Bras Dermatol. 2012;87:435–449.
   PubMed Web of Science ®Google Scholar
• Picard D, Janela B, Descamps V, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med. 2010;2:46ra62.
   PubMed Web of Science ®Google Scholar
• Knowles SR, Uetrecht J, Shear NH. Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet Lond Engl. 2000;356:1587–1591.
   PubMed Web of Science ®Google Scholar
• Descamps V, Ben Saïd B, Sassolas B, et al..Management of drug reaction with eosinophilia and systemic symptoms (DRESS). Ann Dermatol Venereol. 2010;137:703–708.
   Google Scholar
• Kano Y, Hiraharas K, Sakuma K, et al. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol. 2006;155:301–306.
   PubMed Web of Science ®Google Scholar
• Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part I. Clinical perspectives. J Am Acad Dermatol. 2013;68: 693.e1-14. quiz 706-708.
   Web of Science ®Google Scholar
• Thong BY-H. Stevens-Johnson syndrome/toxic epidermal necrolysis: an Asia-Pacific perspective. Asia Pac Allergy. 2013;3:215–223.
   PubMedGoogle Scholar
• Peyrière H, Dereure O, Breton H, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2006;155:422–428.
   PubMed Web of Science ®Google Scholar
• Zaia JA. Viral infections associated with bone marrow transplantation. Hematol Oncol Clin North Am. 1990;4:603–623.
   PubMed Web of Science ®Google Scholar
• Tohyama M, Hashimoto K, Yasukawa M, et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol. 2007;157:934–940.
   PubMed Web of Science ®Google Scholar
• Almudimeegh A, Rioux C, Ferrand H, et al. Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV? Br J Dermatol. 2014;171:895–898.
   PubMed Web of Science ®Google Scholar
• Hislop AD, Taylor GS, Sauce D, et al. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol. 2007;25:587–617.
   PubMed Web of Science ®Google Scholar
• Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int Off J Jpn Soc Allergol. 2006;55:1–8.
   PubMedGoogle Scholar
• Descamps V, Ranger-Rogez S. DRESS syndrome. Jt Bone Spine Rev Rhum. 2014;81:15–21.
   PubMed Web of Science ®Google Scholar
• Roujeau J-C, Dupin N. Virus reactivation in Drug Reaction with Eosinophilia and Systemic Symptoms (Dress) results from a strong drug-specific immune response. J Allergy Clin Immunol Pract. 2017;5:811–812.
   PubMed Web of Science ®Google Scholar
• Shiohara T, Kano Y. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol. 2007;33:124–133.
   PubMed Web of Science ®Google Scholar
• Guillon JM, Joly P, Autran B, et al. Minocycline-induced cell-mediated hypersensitivity pneumonitis. Ann Intern Med. 1992;117:476–481.
   PubMed Web of Science ®Google Scholar
• Santiago F, Gonçalo M, Vieira R, et al. Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS). Contact Dermatitis. 2010;62:47–53.
   PubMed Web of Science ®Google Scholar
• Mennicke M, Zawodniak A, Keller M, et al. Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2009;9:2197–2202.
   PubMed Web of Science ®Google Scholar
• Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol. 2004;140:183–188.
   PubMedGoogle Scholar
• Aihara Y, Ito S-I, Kobayashi Y, et al. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction. Br J Dermatol. 2003;149:165–169.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Fujita A, Yagami A, et al. Human herpesvirus 6 reactivation and inflammatory cytokine production in patients with drug-induced hypersensitivity syndrome. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2006;37 Suppl 1:S92–96.
   Web of Science ®Google Scholar
• Bohan KH, Mansuri TF, Wilson NM. Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care. Pharmacotherapy. 2007;27:1425–1439.
   PubMed Web of Science ®Google Scholar
• Kano Y, Shiohara T. Sequential reactivation of herpesvirus in drug-induced hypersensitivity syndrome. Acta Derm Venereol. 2004;84:484–485.
   PubMed Web of Science ®Google Scholar
• Choquet-Kastylevsky G, Intrator L, Chenal C, et al. Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome. Br J Dermatol. 1998;139:1026–1032.
   PubMed Web of Science ®Google Scholar
• Saha M, Gorai S, Madhab V. Oxcarbazepine-induced drug rash with eosinophilia and systemic symptoms syndrome presenting as exfoliative dermatitis. J Pharmacol Pharmacother. 2016;7:142–145.
   PubMed Web of Science ®Google Scholar
• Bayram AK, Canpolat M, Çınar SL, et al. Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Induced by Levetiracetam in a Pediatric Patient. J Emerg Med. 2016;50:e61–66.
   PubMed Web of Science ®Google Scholar
• Albayrak F, Cerrah S, Albayrak A, et al. DRESS syndrome with fatal results induced by sodium valproate in a patient with brucellosis and a positive cytoplasmic antineutrophilic cytoplasmic antibody test result. Rheumatol Int. 2012;32:2181–2184.
   PubMed Web of Science ®Google Scholar
• Shahbaz S, Sivamani RK, Konia T, et al. A case of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) related to rufinamide. Dermatol Online J. 2013;19:4.
   PubMedGoogle Scholar
• Bensaid B, Rozieres A, Nosbaum A, et al. Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: delayed skin test and ELISPOT assay results allow the identification of the culprit drug. J Allergy Clin Immunol. 2012;130:1413–1414.
   PubMed Web of Science ®Google Scholar
• Mardivirin L, Valeyrie-Allanore L, Branlant-Redon E, et al. Amoxicillin-induced flare in patients with DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on Human Herpesvirus 6 replication in vitro. Eur J Dermatol EJD. 2010;20:68–73.
   PubMed Web of Science ®Google Scholar
• Sussman S, Devlin V, Dimitriades VR. A teenager with sulfasalazine-associated DRESS syndrome after the introduction of amoxicillin. Clin Pediatr (Phila). 2017;56:290–291.
   PubMed Web of Science ®Google Scholar
• Sriratanaviriyakul N, Nguyen L-P, Henderson MC, et al. Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) syndrome associated with azithromycin presenting like septic shock: a case report. J Med Case Reports. 2014;8:332.
   PubMedGoogle Scholar
• Aouam K, Chaabane A, Toumi A, et al. Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) probably induced by cefotaxime: a report of two cases. Clin Med Res. 2012;10:32–35.
   PubMedGoogle Scholar
• Picard M, Fernandez MI, Des Roches A, et al. Ceftazidime-induced drug reaction with eosinophilia and systemic symptoms (DRESS) complicated by hemophagocytic lymphohistiocytosis. J Allergy Clin Immunol Pract. 2013;1:409–412.
   PubMed Web of Science ®Google Scholar
• Guleria VS, Dhillon M, Gill S, et al. Ceftriaxone induced drug rash with eosinophilia and systemic symptoms. J Res Pharm Pract. 2014;3:72–74.
   PubMedGoogle Scholar
• Alkhateeb H, Said S, Cooper CJ, et al. DRESS syndrome following ciprofloxacin exposure: an unusual association. Am J Case Rep. 2013;14:526–528.
   PubMedGoogle Scholar
• Sahnoun R, El Aïdli S, Zaïem A, et al. [DRESS syndrome induced by ciprofloxacine]. Nephrol Ther. 2015;11:111–113.
   PubMed Web of Science ®Google Scholar
• Pereira CM, Vaz M, Kotha S, et al. DAPSONE-INDUCED DRESS: A CASE REPORT. J Assoc Physicians India. 2014;62:728–731.
   PubMedGoogle Scholar
• Balaji O, George M, Meena K, et al. Dapsone-induced DRESS: a case report. Asian J Pharm Clin Res. 2017;10:4–5.
   Google Scholar
• Savard S, Desmeules S, Riopel J, et al. Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Am J Kidney Dis Off J Natl Kidney Found. 2009;54:e17–20.
   PubMed Web of Science ®Google Scholar
• Charfi O, Lakhoua G, Sahnoun R, et al. DRESS syndrome following levofloxacin exposure with positive patch-test. Therapie. 2015;70:547–549.
   PubMed Web of Science ®Google Scholar
• Prados-Castaño M, Piñero-Saavedra M, Leguísamo-Milla S, et al. DRESS syndrome induced by meropenem. Allergol Immunopathol (Madr). 2015;43:233–235.
   PubMed Web of Science ®Google Scholar
• Ebrahimpour S, Mohammadi M, Gholami K. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) with teicoplanin: a case report. Drug Saf - Case Rep. 2017;4:1.
   PubMedGoogle Scholar
• Leão RN, Barreto P, Leão RR, et al. Nitrofurantoin: cause of DRESS syndrome. BMJ Case Rep. 2013;2013. DOI:10.1136/bcr-2013-008991
   Google Scholar
• Lan J, Lahoti A, Lew DB. A severe case of minocycline-induced DRESS resulting in liver transplantation and autoimmune sequelae. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2016;116:367–368.
   PubMed Web of Science ®Google Scholar
• Vauthey L, Uçkay I, Abrassart S, et al. Vancomycin-induced DRESS syndrome in a female patient. Pharmacology. 2008;82:138–141.
   PubMed Web of Science ®Google Scholar
• Blumenthal KG, Patil SU, Long AA. The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Allergy Asthma Proc. 2012;33:165–171.
   PubMed Web of Science ®Google Scholar
• Miyazu D, Kodama N, Yamashita D, et al. DRESS syndrome caused by cross-reactivity between vancomycin and subsequent teicoplanin administration: a case report. Am J Case Rep. 2016;17:625–631.
   PubMed Web of Science ®Google Scholar
• Doña I, Chaves P, Gómez E, et al. Drug rash with eosinophilia and systemic symptoms after penicillin v administration in a patient with acquired C1 inhibitor acquired deficiency. J Investig Allergol Clin Immunol Off Organ Int Assoc Asthmology INTERASMA Soc Latinoam Alerg E Inmunol. 2009;19:325–327.
   Google Scholar
• Cabañas R, Calderon O, Ramirez E, et al. Piperacillin-induced DRESS: distinguishing features observed in a clinical and allergy study of 8 patients. J Investig Allergol Clin Immunol. 2014;24:425–430.
   PubMed Web of Science ®Google Scholar
• Lee J-Y, Seol Y-J, Shin D-W, et al. A case of the Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) following isoniazid treatment. Tuberc Respir Dis. 2015;78:27–30.
   PubMed Web of Science ®Google Scholar
• Jung ES, Choi B, Choi HS, et al. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Induced by Ethambutol and Rifampin. Infect Chemother. 2012;44:197–200.
   Google Scholar
• Kim J-H, Jang SH, Kim DH, et al. A case of DRESS syndrome induced by the antituberculosis drugs, prothionamide, and para-aminosalycilic acid. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2013;110:118–119.
   PubMed Web of Science ®Google Scholar
• Chou H-Y, Chen C-B, Cheng C-Y, et al. Febuxostat-associated drug reaction with eosinophilia and systemic symptoms (DRESS). J Clin Pharm Ther. 2015;40:689–692.
   PubMed Web of Science ®Google Scholar
• Kawakami T, Fujita A, Takeuchi S, et al. Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease. J Am Acad Dermatol. 2009;60:146–149.
   PubMed Web of Science ®Google Scholar
• Koca T, Akcam M. Ibuprofen induced DRESS syndrome in a child. Indian Pediatr. 2016;53:745.
   PubMed Web of Science ®Google Scholar
• Tank ND, Karelia BN, Bhansali NB. Paracetamol induced drug reaction with eosinophilia and systemic symptoms (Dress syndrome): A case report. Int J Pharm Sci Rev Res. 2015;32:246–248.
   Google Scholar
• Valade S, Toledano C, Tiev K, et al. DRESS syndrome caused by phenylbutazone. Rev Med Interne. 2009;30:708–710.
   PubMed Web of Science ®Google Scholar
• Shaaban H, Layne T, Guron G. A case of DRESS (drug reaction with eosinophilia and systemic symptoms) with acute interstitial nephritis secondary to lenalidomide. J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract. 2014;20:302–304.
   PubMed Web of Science ®Google Scholar
• Bianchi L, Caraffini S, Lisi P. Drug reaction with eosinophilia and systemic symptoms syndrome caused by an everolimus-eluting stent. Int J Dermatol. 2014;53:e286–288.
   PubMed Web of Science ®Google Scholar
• Pinto B, Dhir V, Krishnan S, et al. Leflunomide-induced DRESS syndrome with renal involvement and vasculitis. Clin Rheumatol. 2013;32:689–693.
   PubMed Web of Science ®Google Scholar
• Volpe A, Marchetta A, Caramaschi P, et al. Hydroxychloroquine-induced DRESS syndrome. Clin Rheumatol. 2008;27:537–539.
   PubMed Web of Science ®Google Scholar
• Gill S, Sagar A, Shankar S, et al. Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS). Indian J Pharmacol. 2013;45:401–402.
   PubMed Web of Science ®Google Scholar
• Pott Junior H, Gosuen GC, Gales AC. DRESS Syndrome due to Nevirapine Treated with Methylprednisolone. Case Rep Med. 2013;2013. DOI:10.1155/2013/269501
   PubMedGoogle Scholar
• Keohane C, Bacon CL, Moran B, et al. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by cidofovir. Pediatr Transplant. 2011;15:121.
   PubMed Web of Science ®Google Scholar
• Bayonne Kombo ES, Gathse A. Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV. Med Mal Infect. 2013;43:134–135.
   PubMed Web of Science ®Google Scholar
• Perry M, Almaani N, Desai N, et al. Raltegravir-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: implications for clinical practice and patient safety. J Int AIDS Soc. 2010;13:P110.
   Google Scholar
• Samain A, Duval-Modeste A-B, Joly P, et al. First case of drug rash eosinophilia and systemic symptoms due to boceprevir. J Hepatol. 2014;60:891–893.
   PubMed Web of Science ®Google Scholar
• Janocha-Litwin J, Pazgan-Simon M, Simon K. DRESS syndrome as a complication of treatment of hepatitis C virus-associated post-inflammatory liver cirrhosis with peginterferon α2a and ribavirin. Postepy Dermatol Alergol. 2014;31:401–404.
   PubMed Web of Science ®Google Scholar
• Akar T, Kilavuz B, Malkoç D, et al. Telaprevir-induced DRESS syndrome associated with Salmonella typhi. ACG Case Rep J. 2015;2:79–80.
   PubMed Web of Science ®Google Scholar
• Vignesh P, Kishore J, Kumar A, et al. A young child with eosinophilia, rash, and multisystem illness: drug rash, eosinophilia, and systemic symptoms syndrome after receipt of fluoxetine. Pediatr Dermatol. 2017;34:e120–e125.
   PubMed Web of Science ®Google Scholar
• Raz A, Bergman R, Eilam O, et al. A case report of olanzapine-induced hypersensitivity syndrome. Am J Med Sci. 2001;321:156–158.
   PubMed Web of Science ®Google Scholar
• Wenk KS, Pichard DC, Nasabzadeh T, et al. Vemurafenib-induced DRESS. JAMA Dermatol. 2013;149:1242–1243.
   PubMed Web of Science ®Google Scholar
• Munch M, Peuvrel L, Brocard A, et al. Early-onset vemurafenib-induced DRESS syndrome. Dermatol Basel Switz. 2016;232:126–128.
   PubMed Web of Science ®Google Scholar
• Thomas CL, Arasaratnam M, Carlos G, et al. Drug reaction with eosinophilia and systemic symptoms in metastatic basal cell carcinoma treated with vismodegib. Australas J Dermatol. 2017;58:69–70.
   PubMed Web of Science ®Google Scholar
• Allanore Y, Moachon L, Maury E, et al. Bosentan-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. J Rheumatol. 2010;37:1077–1078.
   PubMed Web of Science ®Google Scholar
• Chaabane A, Fadhl NB, Chadly Z, et al. Captopril-induced DRESS: first reported case confirmed by patch test. Dermat Contact Atopic Occup Drug. 2013;24:255–257.
   PubMed Web of Science ®Google Scholar
• Yoo SD, Kim SG, Kim SH, et al. Drug rash with eosinophilia and systemic symptoms syndrome induced by chloral hydrate in early childhood. Allergy Asthma Immunol Res. 2014;6:270–272.
   PubMed Web of Science ®Google Scholar
• Said BB, Rozieres A, Martin O, et al. Severe hypocalcemia and drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome under deferasirox therapy for myelodysplasic syndrome. Am J Hematol. 2012;87:233.
   PubMed Web of Science ®Google Scholar
• Bourneau-Martin D, Leclech C, Jamet A, et al. Omeprazole-induced drug reaction with eosinophilia and systemic symptoms (DRESS). Eur J Dermatol EJD. 2014;24:413–415.
   PubMed Web of Science ®Google Scholar
• Caboni S, Gunera-Saad N, Ktiouet-Abassi S, et al. Esomeprazole-induced DRESS syndrome. Studies of cross-reactivity among proton-pump inhibitor drugs. Allergy. 2007;62:1342–1343.
   PubMed Web of Science ®Google Scholar
• Ronceray S, Dinulescu M, Le Gall F, et al. Enoxaparin-Induced DRESS Syndrome. Case Rep Dermatol. 2012;4:233–237.
   PubMedGoogle Scholar
• Safrano L, Bourneau-Martin D, Le Clech C, et al. Suspicion of fenofibrate-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report. Therapie. 2014;69:461–464.
   PubMed Web of Science ®Google Scholar
• Voore P, Odigwe C, Mirrakhimov AE, et al. DRESS syndrome following metformin administration: a case report and review of the literature. Am J Ther 2016; 23:e1970–e1973.
   Google Scholar
• Michel F, Navellou J-C, Ferraud D, et al. DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis. Jt Bone Spine Rev Rhum. 2005;72:82–85.
   PubMed Web of Science ®Google Scholar
• Viehweg A, Stein A, Bauer A, et al. Potassium-paraaminobenzoic acid (Potaba®)-associated DRESS syndrome. Dermat Contact Atopic Occup Drug. 2013;24:257–258.
   PubMed Web of Science ®Google Scholar
• Le T-M, Sanders CJG, van de Corput L, et al. Drug rash with eosinophilia and systemic symptoms caused by the dietary supplement diindolylmethane. J Allergy Clin Immunol Pract. 2016;4:175–176.
   PubMed Web of Science ®Google Scholar
• Walsh S, Diaz-Cano S, Higgins E, et al. Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases. Br J Dermatol. 2013;168:391–401.
   PubMed Web of Science ®Google Scholar
• De Vriese AS, Philippe J, Van Renterghem DM, et al. Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature. Medicine (Baltimore). 1995;74:144–151.
   PubMed Web of Science ®Google Scholar
• Chi M-H, Hui RC-Y, Yang C-H, et al. Histopathological analysis and clinical correlation of drug reaction with eosinophilia and systemic symptoms (DRESS). Br J Dermatol. 2014;170:866–873.
   PubMedGoogle Scholar
• Ortonne N, Valeyrie-Allanore L, Bastuji-Garin S, et al. Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study. Br J Dermatol. 2015;173:50–58.
   PubMed Web of Science ®Google Scholar
• Um SJ, Lee SK, Kim YH, et al. Clinical features of drug-induced hypersensitivity syndrome in 38 patients. J Investig Allergol Clin Immunol. 2010;20:556–562.
   PubMed Web of Science ®Google Scholar
• Schwartz RA, Husain Z, Reddy BY. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and dysphagia: a noteworthy association. J Am Acad Dermatol. 2013;69:1058.
   PubMed Web of Science ®Google Scholar
• Descamps V. Dysphagia, a major early manifestation in DRESS syndrome. J Am Acad Dermatol. 2013;69:1057–1058.
   PubMed Web of Science ®Google Scholar
• Schwartz RA, Husain Z, Reddy BY. Drug reaction with eosinophilia and systemic symptoms syndrome and toxic epidermal necrolysis: an uncommon confounding oral mucosal overlap. J Am Acad Dermatol. 2013;69:1057.
   PubMed Web of Science ®Google Scholar
• Wang L, Mei X-L. Drug reaction with eosinophilia and systemic symptoms: retrospective analysis of 104 cases over one decade. Chin Med J (Engl). 2017;130:943–949.
   PubMed Web of Science ®Google Scholar
• Gentile I, Talamo M, Borgia G. Severe agranulocytosis in two patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. BMC Infect Dis. 2010;10:49.
   PubMed Web of Science ®Google Scholar
• Criado PR, Criado RFJ, Avancini J de M, et al. Drug Reaction with Eosinophilia and Systemic Symptoms (Dress)/Drug-Induced Hypersensitivity Syndrome (DIHS): a Review of Current Concepts. An Bras Dermatol. 2012;87:435–449.
   PubMed Web of Science ®Google Scholar
• Ben-Ari K, Goldberg I, Shirazi I, et al. An unusual case of DRESS syndrome. J Dermatol Case Rep. 2008;2:39–42.
   PubMedGoogle Scholar
• Kumari R, Timshina DK, Thappa DM. Drug hypersensitivity syndrome. Indian J Dermatol Venereol Leprol. 2011;77:7.
   PubMed Web of Science ®Google Scholar
• Eshki M, Allanore L, Musette P, et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol. 2009;145:67–72.
   PubMed Web of Science ®Google Scholar
• Ghannam M, Mansour S, Nabulsi A, et al. Anticonvulsant hypersensitivity syndrome after phenytoin administration in an adolescent patient: a case report and review of literature. Clin Mol Allergy CMA. 2017;15. DOI:10.1186/s12948-017-0069-0
   Google Scholar
• Pietrafesa D, Vomero A, Giachetto G. Síndrome de hipersensibilidad a anticonvulsivantes: descripción de tres casos clínicos. Arch Pediatría Urug. 2016;87:38–43.
   Google Scholar
• Deka NM, Dass R, Das BK, et al. Phenytoin Induced DRESS Syndrome. Indian J Pediatr. 2013;80:266.
   PubMed Web of Science ®Google Scholar
• Kennebeck GA. Anticonvulsant hypersensitivity syndrome. J Am Board Fam Pract. 2000;13:364–370.
   PubMedGoogle Scholar
• Kato M, Kano Y, Sato Y, et al. Severe agranulocytosis in two patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Acta Derm Venereol. 2016;96:842–843.
   PubMed Web of Science ®Google Scholar
• Oliveira AM, Carvalho R, Martins A, et al. Acute hepatitis in the DRESS syndrome. GE Port J Gastroenterol. 2016;23:304–308.
   Google Scholar
• Bizid S, Haddad W, Ben Abdallah H, et al. Severe acute hepatitis induced by a DRESS syndrome to piroxicam. Tunis Med. 2014;92:417.
   PubMedGoogle Scholar
• van Zoelen MAD, De Graaf M, van Dijk MR, et al. DRESS syndrome: improvement of acute kidney injury and rash with corticosteroids. Neth J Med. 2012;70:155.
   PubMedGoogle Scholar
• Vaish AK, Tripathi AK, Gupta LK, et al. An unusual case of DRESS syndrome due to leflunomide. BMJ Case Rep. 2011;2011. DOI:10.1136/bcr.06.2011.4330
   Google Scholar
• Jennings M, Shortland JR, Maddocks JL. Interstitial nephritis associated with frusemide. J R Soc Med. 1986;79:239–240.
   PubMed Web of Science ®Google Scholar
• Augusto J-F, Sayegh J, Simon A, et al. Extensive pulmonary involvement with raltegravir-induced DRESS syndrome in a postpartum woman with HIV. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2009;24:2940–2942.
   PubMed Web of Science ®Google Scholar
• O’Meara P, Borici-Mazi R, Morton AR, et al. DRESS with delayed onset acute interstitial nephritis and profound refractory eosinophilia secondary to Vancomycin. Allergy Asthma Clin Immunol Off J Can Soc Allergy Clin Immunol. 2011;7:16.
   PubMed Web of Science ®Google Scholar
• Yee BE, Nguyen NH, Lee D. Extensive pulmonary involvement with raltegravir-induced DRESS syndrome in a postpartum woman with HIV. BMJ Case Rep. 2014;2014. DOI:10.1136/bcr-2013-201545
   Google Scholar
• Bernez A, Perrinaud A, Abdallah-Lotf M, et al. DRESS syndrome with severe pulmonary involvement following oral intake of a homeopathic drug. Ann Dermatol Venereol. 2008;135:140–142.
   PubMed Web of Science ®Google Scholar
• Yu M-K, Yu M-C, Lee F. Association of DRESS syndrome with chylous ascites. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2006;21:3301–3303.
   PubMed Web of Science ®Google Scholar
• Tonekaboni SH, Jafari N, Chavoshzadeh Z, et al. DRESS syndrome presents as leukoencephalopathy. Turk J Pediatr. 2015;57:541–544.
   PubMed Web of Science ®Google Scholar
• Thongsri T, Chularojanamontri L, Pichler WJ. Cardiac involvement in DRESS syndrome. Asian Pac J Allergy Immunol. 2017;35:3–10.
   PubMed Web of Science ®Google Scholar
• Bourgeois GP, Cafardi JA, Groysman V, et al. A review of DRESS-associated myocarditis. J Am Acad Dermatol. 2012;66:e229–236.
   PubMed Web of Science ®Google Scholar
• Bourgeois GP, Cafardi JA, Groysman V, et al. Fulminant myocarditis as a late sequelae of DRESS-2 cases. J Am Acad Dermatol. 2011;65:889–890.
   PubMed Web of Science ®Google Scholar
• Yazicioglu M, Elmas R, Turgut B, et al. The association between DRESS and the diminished numbers of peripheral B lymphocytes and natural killer cells. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2012;23:289–296.
   PubMed Web of Science ®Google Scholar
• Vidula N, Qamar N, Kurahashi C, et al. Encephalopathy and strokes secondary to drug reaction with eosinophilia and systemic symptoms: a case report. J Allergy Clin Immunol Pract. 2014;2:222–224.
   PubMed Web of Science ®Google Scholar
• Bohm KJ, Ciralsky JB, Harp JL, et al. Cicatrizing conjunctivitis in a patient diagnosed with drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome but with features of stevens-johnson syndrome. Cornea. 2016;35:888–891.
   PubMed Web of Science ®Google Scholar
• Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg. 1996;15:250–257.
   PubMed Web of Science ®Google Scholar
• Grover S. Severe cutaneous adverse reactions. Indian J Dermatol Venereol Leprol. 2011;77:3.
   PubMed Web of Science ®Google Scholar
• Kim D-H, Koh Y-I. Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome. Allergy Asthma Immunol Res. 2014;6:216–221.
   PubMed Web of Science ®Google Scholar
• Chan J, Chan H, Yeung C. Drug reaction with eosinophilia and systemic symptoms(DRESS). Hong Kong J Dermatol Venereol. 2012;20:163–170.
   Web of Science ®Google Scholar
• Cardoso CS, Vieira AM, Oliveira AP. DRESS syndrome: a case report and literature review. BMJ Case Rep. 2011;2011. DOI:10.1136/bcr.02.2011.3898
   Google Scholar
• Bachot N, Roujeau J-C. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol. 2003;4:561–572.
   PubMed Web of Science ®Google Scholar
• Hamm RL. Drug-Hypersensitivity Syndrome: diagnosis and Treatment. J Am Coll Clin Wound Spec. 2012;3:77–81.
   PubMedGoogle Scholar
• Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part II. Management and Therapeutics. J Am Acad Dermatol. 2013;68: 709.e1-9. quiz 718-720.
   Google Scholar
• Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124:588–597.
   PubMed Web of Science ®Google Scholar
• Davern TJ. Drug-induced liver disease. Clin Liver Dis. 2012;16:231–245.
   PubMed Web of Science ®Google Scholar
• Zuliani E, Zwahlen H, Gilliet F, et al. Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment. Clin Nephrol. 2005;64:155–158.
   PubMed Web of Science ®Google Scholar
• Kirchhof MG, Wong A, Dutz JP. Cyclosporine treatment of drug-induced hypersensitivity syndrome. JAMA Dermatol. 2016;152:1254–1257.
   PubMed Web of Science ®Google Scholar
• Bommersbach TJ, Lapid MI, Leung JG, et al. Management of psychotropic drug-induced DRESS syndrome: a systematic review. Mayo Clin Proc. 2016;91:787–801.
   PubMed Web of Science ®Google Scholar
• Joly P, Janela B, Tetart F, et al. Poor benefit/risk balance of intravenous immunoglobulins in DRESS. Arch Dermatol. 2012;148:543–544.
   PubMedGoogle Scholar
• Singer EM, Wanat KA, Rosenbach MA. A case of recalcitrant DRESS syndrome with multiple autoimmune sequelae treated with intravenous immunoglobulins. JAMA Dermatol. 2013;149:494–495.
   PubMed Web of Science ®Google Scholar
• Moling O, Tappeiner L, Piccin A, et al. Treatment of DIHS/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir–a hypothesis. Med Sci Monit Int Med J Exp Clin Res. 2012;18:CS57–62.
   Google Scholar
• Shaughnessy KK, Bouchard SM, Mohr MR, et al. Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis. J Am Acad Dermatol. 2010;62:315–318.
   PubMed Web of Science ®Google Scholar
• Alexander T, Iglesia E, Park Y, et al. Severe DRESS syndrome managed with therapeutic plasma exchange. Pediatrics. 2013;131:e945–949.
   PubMed Web of Science ®Google Scholar
• Hall DJ, Fromm JS. Drug reaction with eosinophilia and systemic symptoms syndrome in a patient taking phenytoin and levetiracetam: a case report. J Med Case Reports. 2013;7:2.
   PubMedGoogle Scholar
• Ushigome Y, Kano Y, Ishida T, et al. Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution. J Am Acad Dermatol. 2013;68:721–728.
   PubMed Web of Science ®Google Scholar
• Chen Y-C, Chang C-Y, Cho Y-T, et al. Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan. J Am Acad Dermatol. 2013;68:459–465.
   PubMed Web of Science ®Google Scholar
• Matta JMR, Flores SM, Cherit JD. Drug reaction with eosinophilia and systemic symptoms (DRESS) and its relation with autoimmunity in a reference center in Mexico. An Bras Dermatol. 2017;92:30–33.
   PubMed Web of Science ®Google Scholar
• Hirsch LJ, Arif H, Nahm EA, et al. Cross-sensitivity of skin rashes with antiepileptic drug use. Neurology. 2008;71:1527–1534.
   PubMed Web of Science ®Google Scholar
• Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the Prospective RegiSCAR Study. Br J Dermatol. 2013;169:1071–1080.
   Google Scholar